Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 

Question 4: Short-term Objective B

green dot 4SB. Standardize and validate at least 20 model systems (e.g., cellular and/or animal) that replicate features of ASD and will allow identification of specific molecular targets or neural circuits amenable to existing or new interventions by 2012. IACC Recommended Budget: $75,000,000 over 5 years.

Projects Found: 96
Total Funding: 15303589
Records
Project Title Funding Funding Institution

Project Title

Identifying therapeutic targets for autism using Shank3-deficient mice
$487,448

Funding

487448

Institution

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

Project Title

Effects of Chronic Intranasal Oxytocin
$1,105,938

Funding

1105938

Institution

University of California, Davis

Project Title

Roles of Oxytocin and Vasopressin in Brain
$1,866,157

Funding

1866157

Institution

National Institutes of Health

Project Title

Oxytocin Receptors and Social Behavior
$440,363

Funding

440363

Institution

Emory University

Project Title

Functional analysis of the Schizophrenia and Autism Spectrum Disorder gene TCF4 i
$457,500

Funding

457500

Institution

LIEBER INSTITUTE, INC.

Project Title

Prefrontal function in the Shank3-deficient rat: A first rat model for ASD
$457,912

Funding

457912

Institution

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

Project Title

Studies of genetic and metabolic disorders, autism and premature aging
$34,275

Funding

34275

Institution

National Institutes of Health

Project Title

Stable Zebrafish Models of Autism Spectrum Disorder
$75,250

Funding

75250

Institution

University of Miami

Project Title

Functional Analysis of Rare Variants in Genes Associated with Autism
$147,905

Funding

147905

Institution

Yale University

Project Title

Targeting System Xc- for the treatment of the Autism Spectrum Disorder subpopulations, Fragile X syndrome and Phelan-McDermid syndrome
$151,366

Funding

151366

Institution

PROMENTIS PHARMACEUTICALS, INC.

 
Back to Top